Nuclear Imaging Market Size, Share, Trends, Growth Outlook

Nuclear Imaging Market is estimated to increase at a growth rate of 6.3% CAGR over the forecast period from 2024 to 2030.

The global Nuclear Imaging Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Equipment, Radioisotope (SPECT Radioisotopes, PET Radioisotopes)), By Application (SPECT Application (Cardiology, Neurology, Thyroid), PET Applications (Cardiology, Oncology, Neurology)).

An Introduction to Nuclear Imaging Market in 2024

Nuclear Imaging continues to play a pivotal role in diagnostic medicine, providing invaluable insights into physiological processes, disease pathology, and treatment response in 2024. The Nuclear Imaging Market is witnessing sustained growth and technological innovation as healthcare providers and imaging centers leverage a diverse array of radiopharmaceuticals and imaging modalities for clinical applications ranging from oncology and cardiology to neurology and nuclear medicine. With advancements in hybrid imaging techniques such as positron emission tomography-computed tomography (PET-CT) and single-photon emission computed tomography-computed tomography (SPECT-CT), there is growing demand for multimodal imaging solutions capable of delivering comprehensive diagnostic information with enhanced sensitivity, specificity, and spatial resolution. Moreover, ongoing research efforts are focused on developing novel radiotracers, image reconstruction algorithms, and quantitative imaging biomarkers to further improve diagnostic accuracy, therapeutic monitoring, and patient outcomes across a broad spectrum of medical conditions.

Nuclear Imaging Market Competitive Landscape

The global Nuclear Imaging Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Nuclear Imaging Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Nuclear Imaging Industry include- Bracco Imaging SpA, Canon Medical Systems Corp, Cardinal Health Inc, CMR Naviscan , Curium, General Electric Company, Koninklijke Philips NV, Nordion Inc, NTP Radioisotopes SOC, Siemens Healthineers AG.

Nuclear Imaging Market Trend: Advancements in Nuclear Imaging Technologies

In the Nuclear Imaging market, a prominent trend is the continual advancements in nuclear imaging technologies. Nuclear imaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), play a crucial role in the diagnosis, staging, and monitoring of various diseases, including cancer, cardiovascular disorders, and neurological conditions. Recent innovations in nuclear imaging hardware, software, and radiopharmaceutical development have led to improvements in image quality, sensitivity, and spatial resolution, enhancing the diagnostic accuracy and clinical utility of nuclear imaging modalities. Additionally, the integration of hybrid imaging systems, such as PET/CT and PET/MRI, allows for comprehensive anatomical and functional imaging, facilitating more precise disease characterization and treatment planning. The continual advancements in nuclear imaging technologies drive market growth, expand clinical applications, and contribute to improved patient care outcomes in the Nuclear Imaging segment.

Nuclear Imaging Market Driver: Rising Incidence of Chronic Diseases and Demand for Early Diagnosis

The primary market driver for Nuclear Imaging is the rising incidence of chronic diseases and the demand for early diagnosis. Chronic conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders impose a significant burden on healthcare systems worldwide, emphasizing the importance of early detection and timely intervention. Nuclear imaging modalities offer non-invasive, sensitive, and quantitative assessments of physiological and molecular processes within the body, enabling early detection of disease, accurate staging, and treatment response monitoring. The increasing prevalence of chronic diseases, coupled with the growing emphasis on preventive healthcare and personalized medicine, drives demand for nuclear imaging technologies as essential tools for disease diagnosis, risk stratification, and therapeutic decision-making. This, in turn, fuels market growth and innovation in the Nuclear Imaging segment.

Nuclear Imaging Market Opportunity: Expansion into Emerging Applications and Developing Markets

An emerging opportunity in the Nuclear Imaging market lies in the expansion into emerging applications and developing markets. While nuclear imaging technologies have established themselves as valuable diagnostic tools in oncology, cardiology, and neurology, there are opportunities for growth in emerging applications such as infectious disease imaging, musculoskeletal imaging, and molecular imaging of metabolic disorders. Additionally, the penetration of nuclear imaging technologies into developing markets, including Asia-Pacific, Latin America, and the Middle East, presents opportunities for market expansion and revenue growth. Factors such as increasing healthcare infrastructure investment, rising disposable incomes, and growing awareness of advanced diagnostic technologies contribute to the adoption of nuclear imaging modalities in these regions. Collaborative partnerships, regulatory harmonization efforts, and technology transfer initiatives are essential for capitalizing on opportunities in emerging applications and developing markets, driving market expansion and improving access to nuclear imaging services globally.

Nuclear Imaging Market Share Analysis: PET Radioisotopes for Nuclear Imaging is the fastest growing market segment over the forecast period to 2030

Among the various products in nuclear imaging, PET (Positron Emission Tomography) radioisotopes stand out as the fastest-growing segment. This growth is driven by several factors, including advancements in PET imaging technology, expanding clinical applications, and increasing demand for precise diagnostic and therapeutic solutions in oncology and cardiology. PET radioisotopes, such as Fluorine-18 (F-18) and Rubidium-82 (RB-82), offer superior imaging capabilities with high sensitivity and resolution, allowing for the detection and characterization of metabolic processes within the body at the molecular level. In oncology, PET imaging plays a critical role in cancer staging, treatment planning, and response assessment, enabling clinicians to tailor therapies based on individual patient characteristics and disease biology. Additionally, PET imaging is widely utilized in cardiology for the evaluation of myocardial perfusion, viability, and function, contributing to the early detection and management of cardiovascular diseases. With ongoing research and development efforts aimed at expanding the repertoire of PET tracers and optimizing imaging protocols, the adoption of PET radioisotopes is expected to continue its rapid growth trajectory, offering clinicians invaluable insights into disease pathophysiology and guiding personalized patient care across a spectrum of medical specialties.

Nuclear Imaging Market Segmentation

By Product
Equipment
Radioisotope
-SPECT Radioisotopes
--Technetium-99m (TC-99m)
--Thallium-201 (TI-201)
--Gallium (Ga-67)
--Iodine (I-123)
--Others
PET Radioisotopes
--Fluorine-18 (F-18)
--Rubidium-82 (RB-82)
--Others
By Application
SPECT Applications
-Cardiology
-Neurology
-Thyroid
-Others
PET Applications
-Oncology
-Cardiology
-Neurology
-Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Nuclear Imaging Companies

Bracco Imaging SpA
Canon Medical Systems Corp
Cardinal Health Inc
CMR Naviscan
Curium
General Electric Company
Koninklijke Philips NV
Nordion Inc
NTP Radioisotopes SOC
Siemens Healthineers AG
* List not Exhaustive

Reasons to Buy the Nuclear Imaging Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Nuclear Imaging Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Nuclear Imaging Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Nuclear Imaging Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Nuclear Imaging Market Size Outlook, $ Million, 2021 to 2030
3.2 Nuclear Imaging Market Outlook by Type, $ Million, 2021 to 2030
3.3 Nuclear Imaging Market Outlook by Product, $ Million, 2021 to 2030
3.4 Nuclear Imaging Market Outlook by Application, $ Million, 2021 to 2030
3.5 Nuclear Imaging Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Nuclear Imaging Industry
4.2 Key Market Trends in Nuclear Imaging Industry
4.3 Potential Opportunities in Nuclear Imaging Industry
4.4 Key Challenges in Nuclear Imaging Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Nuclear Imaging Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Nuclear Imaging Market Outlook by Segments
7.1 Nuclear Imaging Market Outlook by Segments, $ Million, 2021- 2030
By Product
Equipment
Radioisotope
-SPECT Radioisotopes
--Technetium-99m (TC-99m)
--Thallium-201 (TI-201)
--Gallium (Ga-67)
--Iodine (I-123)
--Others
PET Radioisotopes
--Fluorine-18 (F-18)
--Rubidium-82 (RB-82)
--Others
By Application
SPECT Applications
-Cardiology
-Neurology
-Thyroid
-Others
PET Applications
-Oncology
-Cardiology
-Neurology
-Others
8 North America Nuclear Imaging Market Analysis and Outlook To 2030
8.1 Introduction to North America Nuclear Imaging Markets in 2024
8.2 North America Nuclear Imaging Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Nuclear Imaging Market size Outlook by Segments, 2021-2030
By Product
Equipment
Radioisotope
-SPECT Radioisotopes
--Technetium-99m (TC-99m)
--Thallium-201 (TI-201)
--Gallium (Ga-67)
--Iodine (I-123)
--Others
PET Radioisotopes
--Fluorine-18 (F-18)
--Rubidium-82 (RB-82)
--Others
By Application
SPECT Applications
-Cardiology
-Neurology
-Thyroid
-Others
PET Applications
-Oncology
-Cardiology
-Neurology
-Others
9 Europe Nuclear Imaging Market Analysis and Outlook To 2030
9.1 Introduction to Europe Nuclear Imaging Markets in 2024
9.2 Europe Nuclear Imaging Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Nuclear Imaging Market Size Outlook by Segments, 2021-2030
By Product
Equipment
Radioisotope
-SPECT Radioisotopes
--Technetium-99m (TC-99m)
--Thallium-201 (TI-201)
--Gallium (Ga-67)
--Iodine (I-123)
--Others
PET Radioisotopes
--Fluorine-18 (F-18)
--Rubidium-82 (RB-82)
--Others
By Application
SPECT Applications
-Cardiology
-Neurology
-Thyroid
-Others
PET Applications
-Oncology
-Cardiology
-Neurology
-Others
10 Asia Pacific Nuclear Imaging Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Nuclear Imaging Markets in 2024
10.2 Asia Pacific Nuclear Imaging Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Nuclear Imaging Market size Outlook by Segments, 2021-2030
By Product
Equipment
Radioisotope
-SPECT Radioisotopes
--Technetium-99m (TC-99m)
--Thallium-201 (TI-201)
--Gallium (Ga-67)
--Iodine (I-123)
--Others
PET Radioisotopes
--Fluorine-18 (F-18)
--Rubidium-82 (RB-82)
--Others
By Application
SPECT Applications
-Cardiology
-Neurology
-Thyroid
-Others
PET Applications
-Oncology
-Cardiology
-Neurology
-Others
11 South America Nuclear Imaging Market Analysis and Outlook To 2030
11.1 Introduction to South America Nuclear Imaging Markets in 2024
11.2 South America Nuclear Imaging Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Nuclear Imaging Market size Outlook by Segments, 2021-2030
By Product
Equipment
Radioisotope
-SPECT Radioisotopes
--Technetium-99m (TC-99m)
--Thallium-201 (TI-201)
--Gallium (Ga-67)
--Iodine (I-123)
--Others
PET Radioisotopes
--Fluorine-18 (F-18)
--Rubidium-82 (RB-82)
--Others
By Application
SPECT Applications
-Cardiology
-Neurology
-Thyroid
-Others
PET Applications
-Oncology
-Cardiology
-Neurology
-Others
12 Middle East and Africa Nuclear Imaging Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Nuclear Imaging Markets in 2024
12.2 Middle East and Africa Nuclear Imaging Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Nuclear Imaging Market size Outlook by Segments, 2021-2030
By Product
Equipment
Radioisotope
-SPECT Radioisotopes
--Technetium-99m (TC-99m)
--Thallium-201 (TI-201)
--Gallium (Ga-67)
--Iodine (I-123)
--Others
PET Radioisotopes
--Fluorine-18 (F-18)
--Rubidium-82 (RB-82)
--Others
By Application
SPECT Applications
-Cardiology
-Neurology
-Thyroid
-Others
PET Applications
-Oncology
-Cardiology
-Neurology
-Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Bracco Imaging SpA
Canon Medical Systems Corp
Cardinal Health Inc
CMR Naviscan
Curium
General Electric Company
Koninklijke Philips NV
Nordion Inc
NTP Radioisotopes SOC
Siemens Healthineers AG
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Equipment
Radioisotope
-SPECT Radioisotopes
--Technetium-99m (TC-99m)
--Thallium-201 (TI-201)
--Gallium (Ga-67)
--Iodine (I-123)
--Others
PET Radioisotopes
--Fluorine-18 (F-18)
--Rubidium-82 (RB-82)
--Others
By Application
SPECT Applications
-Cardiology
-Neurology
-Thyroid
-Others
PET Applications
-Oncology
-Cardiology
-Neurology
-Others